Readers Digest
Magazine subscription Podcast
HomeHealthHealth Conditions

How Deep Brain Stimulation can help Parkinson’s

How Deep Brain Stimulation can help Parkinson’s

Not quite a cure, but electrical stimulation deep within the Parkinson’s brain can reduce some of the most disabling symptoms. Helen Cowan interviews consultant neurologist Dr Binith Cheeran about how this procedure helps those suffering. 

Who could benefit from Deep Brain Stimulation (DBS)?

Previously, only people with more severe Parkinson’s were offered DBS. However, DBS is now approved for people who have had Parkinson’s for more than 4 years and have just started to experience fluctuations in the control of their symptoms despite taking medication.

The hope is that DBS will better control symptoms in these patients, enabling them to maintain friendships, social interaction, employment, and activity translating into improved quality of life.

DBS is also used to treat other diseases causing tremor, muscle spasms and contractions. It is being evaluated as a treatment for some forms of epilepsy, Tourette’s and some psychiatric diseases.



What happens in the procedure?

Surgeons drill a small hole in the skull and place specially-made wires (leads) into specific parts of the brain with careful precision, guided by a special guidance frame or robot. The leads are connected to an electrical pulse generator (like a pacemaker) placed under the skin over the chest.

The procedure, which can last as little as 3 hours, is often done with the patient awake. This allows the experienced DBS neurologist to check that the wires are correctly placed to control symptoms without stimulating unintended parts of the brain.

DBS is then switched on (often a few weeks later), and the ‘dose’ of electrical stimulation is programmed by a specialist to suppress symptoms of the disease.



Are there any risks?

DBS should only be carried out by experienced teams, after careful evaluation of the risks and potential benefits. Potential risks, though rare, include bleeding in the brain, infection, and the risk that the leads delivering the therapy are not optimally placed (leading to side-effects with stimulation).



What are the alternatives?

If tablets are not controlling symptoms, other therapies include pumps that deliver gel or liquid medicines directly into the gut or through a needle placed just under the skin. These treatments may suit some people with Parkinson’s, but for most DBS delivers a better quality of life.

Scientists are looking into therapies like stem cell treatments and growth factors, but these have not yet delivered the improvements in quality of life that DBS can offer.



What does the future hold for DBS?

DBS is going through a phase of rapid innovation.

Traditionally, the electrical currents from the leads in the brain resembled light coming from a bulb, travelling in all directions. Technology has been developed to steer the electrical current in a specific direction in the brain, away from unwanted structures and towards the target brain structure—rather like light from a torch—making it even safer.

In the future, DBS systems will be able to automatically adjust the dose of stimulation to symptom severity, crucial in a disease that varies in severity from day to day like Parkinson’s.

Some DBS systems being implanted today are already equipped to respond to measurements from devices like an Apple Watch, and such technology should be available in clinical trials within a year.


Helen Cowan completed a PhD in cardiac pharmacology at Oxford in 2002. She is a qualified nurse and has written for the British Journal of Cardiac Nursing, and worked as a columnist for the Nursing TimesRead more from Helen here.

Like us on Facebook and follow us on Twitter for more inspiring health stories

This post contains affiliate links, so we may earn a small commission when you make a purchase through links on our site at no additional cost to you. Read our disclaimer

Loading up next...
Stories by email|Subscription
Readers Digest

Launched in 1922, Reader's Digest has built 100 years of trust with a loyal audience and has become the largest circulating magazine in the world

Readers Digest
Reader’s Digest is a member of the Independent Press Standards Organisation (which regulates the UK’s magazine and newspaper industry). We abide by the Editors’ Code of Practice and are committed to upholding the highest standards of journalism. If you think that we have not met those standards, please contact 0203 289 0940. If we are unable to resolve your complaint, or if you would like more information about IPSO or the Editors’ Code, contact IPSO on 0300 123 2220 or visit